Please refer the attachment.

29th September, 2026 BSE Limited National Stock Exchange of India Limited P.J. Towers, Dalal Street, Fort, Exchange Plaza, Bandra-Kurla Complex, Mumbai- 400 001 Bandra (East), Mumbai – 400 051 BSE scrip code: 543635 NSE symbol: PPLPHARMA Subject: Intimation of closure of trading window Dear Sir / Madam, Pursuant to the provisions of the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 and in terms of the Company’s Code of Conduct to regulate, monitor and report trading by Designated Persons (‘the Code’), we wish to inform you that the Trading Window for dealing in securities of Piramal Pharma Limited shall remain closed for all Designated Persons and their immediate relatives covered under the Code from Thursday, October 1, 2026 until 48 hours after declaration of the unaudited financial results of the Company for the half year ending September 30, 2026. The date of the Board Meeting to approve the said financial results, shall be communicated in due course. Kindly take the above on record. Thank you. Yours truly, For Piramal Pharma Limited Maneesh Sharma Company Secretary & Compliance Officer Piramal Pharma Limited CIN: L24297MH2020PLC338592 Registered Office: Ananta Building, Piramal Corporate Park, Opp. Fire Brigade, Kamani Junction, LBS Marg, Kurla (West), Mumbai – 400070, Maharashtra, India Tel No. +91 22 3802 3000 / 4000; Email Id: shareholders.ppl@piramal.com www.piramalpharma.com